McKesson Corporation (MCK) Shares are Down -5.64%

McKesson Corporation (MCK) : During the past 4 weeks, traders have been relatively bearish on McKesson Corporation (MCK), hence the stock is down -12.51% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -6.14% relative to the S&P 500. The 4-week change in the price of the stock is -14.28% and the stock has fallen -5.64% in the past 1 week.

The stock has recorded a 20-day Moving Average of 9.38% and the 50-Day Moving Average is 12.77%.The 200 Day SMA reached 5.94% McKesson Corporation has dropped 6.39% during the last 3-month period . Year-to-Date the stock performance stands at -15.34%.


McKesson Corporation (MCK) stock is expected to deviate a maximum of $16.41 from the average target price of $206.11 for the short term period. 9 Street Experts have initiated coverage on the stock with the most promising target being $230 and the most muted being $172.

For the current week, the company shares have a recommendation consensus of Buy. McKesson Corporation (NYSE:MCK): stock was range-bound between the intraday low of $164.02 and the intraday high of $168.66 after having opened at $168.24 on Fridays session. The stock finally closed in the red at $168.24, a loss of -1.66%. The stock remained in the red for the whole trading day. The total traded volume was 5,998,039 shares. The stock failed to cross $168.66 in Fridays trading. The stocks closing price on Thursday was $168.97.

McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two business segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical, patient care, financial, supply chain and strategic management software solutions, as well as connectivity, outsourcing and other services, including remote hosting and managed services, to healthcare organizations.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.